Boehringer launches at long-end of Schuldschein mart
Boehringer Ingelheim, the German pharmaceutical group, has decided to tap the long end of the Schuldschein market by launching a 10 year deal. The note is understood to be the first of that tenor in 2009 and is clear sign of the market’s recovery, according to bankers.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
